Decrease of Klotho in the Kidney of Streptozotocin-Induced Diabetic Rats by Cheng, Meng-Fu et al.
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 513853, 7 pages
doi:10.1155/2010/513853
Research Article
DecreaseofKlothointheKidneyofStreptozotocin-Induced
DiabeticRats
Meng-Fu Cheng,1,2 Li-Jen Chen,3 andJuei-TangCheng3,4,5
1Division of Nephrology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan City 70101, Taiwan
2Graduate Institute of Clinical Medicine, College of Medicine, National Cheng Kung University Hospital, Tainan City 70101, Taiwan
3Graduate Institute of Basic Medical Science, College of Medicine, National Cheng Kung University Hospital,
Tainan City 70101, Taiwan
4Department of Pharmacology, College of Medicine, National Cheng Kung University Hospital, Tainan City 70101, Taiwan
5Department of Medical Research, Chi-Mei Medical Center, Yong Kang City 73101, Taiwan
Correspondence should be addressed to Juei-Tang Cheng, jtcheng@mail.ncku.edu.tw
Received 24 February 2010; Accepted 22 April 2010
Academic Editor: Nathan Ames Ellis
Copyright © 2010 Meng-Fu Cheng et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
The klotho gene is expressed in a limited number of tissues, most notably in distal convoluted tubules in the kidney and choroid
plexus in the brain. A previous study suggested that Klotho increases resistance to oxidative stress. However, changes of Klotho
expression in high glucose-induced oxidative stress remain unclear. In the present study, we used streptozotocin-induced diabetic
rats (STZ rats) to examine the eﬀects of insulin, phloridzin or antioxidant, tiron on diabetic nephropathy. Both insulin and
phloridzin reversed the lower Klotho expression levels in kidneys of STZ rats by the correction of hyperglycemia. Also, renal
functionswereimprovedbythesetreatments.Inadditiontotheimprovementofrenalfunctions,thedecreaseofKlothoexpression
in kidney of STZ rats was also reversed by tiron without changing blood glucose levels. The reduction of oxidative stress induced
by high glucose can be considered for this action of tiron. This view was further conﬁrmed in vitro using high glucose-exposed
Madin-Darby canine kidney (MDCK) epithelial cells. Thus, we suggest that decrease of oxidative stress is not only responsible for
the improvement of renal function but also for the recovery of Klotho expression in kidney of STZ rats.
1.Introduction
The Klotho gene, named from a Greek goddess who spins
the thread of life, was identiﬁed in 1997 as a gene mutated
in the Klotho mouse, which exhibited multiple disorders
resembling human premature-aging syndrome [1]. It is
expressed in a limited numbers of tissues, most notably in
distal convoluted tubules of kidney and choroid plexus of
brain [1].
A previous study showed that overexpression of Klotho
in a mouse model of glomerulonephritis restored mitochon-
drial function and suppressed mitochondrial DNA damage
in kidney [2]. It also suppressed the accelerated cellular
senescence and apoptosis induced by glomerulonephritis,
resulting in preservation of renal function and improvement
of survival [2]. These results suggest that Klotho seems
related to increased resistance to oxidative stress [2].
Hyperglycemia is a main factor in the induction of
diabetic nephropathy [3]. Research shows that early blood
glucose control can reduce the incidence of diabetic
nephropathy [4]. Hyperglycemic damage to mesangial cells
is implicated in the development of diabetic nephropathy
[5, 6]. One possibility is that high glucose levels induce
excessive production of reactive oxygen species (ROS) in
mesangial cells, causing damage to these cells [7]. Improve-
ments in diabetes-induced renal dysfunction and/or diabetic
nephropathy using antioxidants lend evidence to the role of
ROS in kidney damage [5]. But the eﬀect of ROS on changes
of Klotho expression in diabetic nephropathy is unknown.
In present study we investigated changes in Klotho
expression in diabetic nephropathy using type 1-like diabetic
rats showing diabetic nephropathy [8]. We examined the
eﬀect of insulin and ﬂoridzin on hyperglycemia in diabetic2 Journal of Biomedicine and Biotechnology
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Figure 1: Kidney sections of STZ rat treatmented with isulin, phlorizin, and tiron. Histology of kidneys were characterized by staining with
hematoxylin-eosin staining (Magniﬁcation: 400x). (a) normal wistar, (b) STZ rats, (c) insulin treated STZ rats, (d) phlorizin-treated STZ
rats, and (e) tiron-treated STZ rats.
rats and we tested the eﬀect of a famous antioxidant, referred
to as tiron on renal, function, and expression of Klotho in
thesekidneys.TheroleofoxidativestressinchangeofKlotho
expression was further characterized in cultured Madin-
Darby Canine Kidney (MDCK) epithelial cells [9].
2.MaterialsandMethods
2.1. Animal Model. Male Wistar rats, aged 6 weeks, were
obtained from the Animal Center of National Cheng Kung
University Medical College. Diabetic rats were induced
by intravenously (i.v.) injecting streptozotocin (65mg/kg)
(Sigma-Aldrich Inc., USA) into fasting rats as described
previously[8].Animalswereconsideredtobediabetic ifthey
had elevated plasma glucose concentrations of 350mg/dL.
Then, these type 1-like diabetic rats, rerﬀered to as STZ rats,
were considered to show diabetic nephropathy if their blood
urea nitrogen (BUN) and creatinine values were elevated.
All experiments were carried out at 9 weeks after diabetes
induction. All animal procedures were performed according
to the Guide for the Care and Use of Laboratory Animals of
the National Institutes of Health.
For correction of hyperglycemia, STZ rats were injected
intraperitoneally (i.p.) with long-lasting human insulin
(Monotard HM., Denmark; 1IU/kg) or phloridzin (1mg/kg;
Fluka Chemie AG, Switzerland), three times a day for 7 days
as described previously [8, 10]. The age-matched rats were
divided into four groups (n = 6): vehicle-treated normal
rats, vehicle-treated STZ rats, insulin-treated STZ rats, and
phloridzin-treated STZ rats. In another experiment, rats
prepared as the above were randomly divided into three
groups (n = 6): vehicle-treated normal rats; vehicle-treated
STZ rats, and tiron-treated (i.p. at 300mg/kg; 3 times/day)
STZ rats.
The levels of plasma glucose, BUN, and creatinine, were
measured in blood samples collected from the femoral vein
of anesthetized rats (pentobarbital, 30mg/kg, i.p.) one hour
before treatment. Body temperature was also monitored
duringtheexperiment.Attheendoftreatment,animalswere
sacriﬁced and kidneys were dissected, washed with saline,
weighed for analysis, and frozen in liquid nitrogen to store
at −80◦C for future analysis.
Blood samples from rats were centrifuged at 12,000g for
3 minutes. Samples were then analyzed using glucose, BUN,
and creatinine kit reagents (AppliedBio assay kits; Hercules,
CA, USA). The levels of plasma glucose, BUN, and serum
creatinine were then estimated by an autoanalyzer (Quik-
Lab, USA) run in duplicate.
2.2. Western Blot Analysis. Protein expression levels of
Klotho in rat kidneys or MDCK cells were determined by
western blot analysis. RIPA buﬀer (25mM Tris • HCl pH
7.6, 150mM NaCl, 1% NP-40, 1% sodium deoxycholate,
0.1% SDS) was used to extract total protein. Protein
extracts were separated by SDS-PAGE, electrotransfered, and
immobilized on a nitrocellulose membrane. The membrane
was blocked with 5% nonfat milk in phosphate-buﬀered
saline containing 0.1% Tween 20 (PBS-T) and incubated for
2 hours. The membrane was then washed in PBS-T and
hybridized with primary antibodies, which were diluted to
a suitable concentration in PBS-T for 16 hours. Speciﬁc
antibodies purchased from Abgent (San Diego, CA, USA)
for Klotho (1:1000) were used. Incubation with secondary
antibodies and detection of the antigen-antibody complexJournal of Biomedicine and Biotechnology 3
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Figure 2: Alteration of superoxide generation (ROS) in the kidneys
of STZ-diabetic rats treatmented with tiron. Klotho protein in the
kidneys of STZ-diabetic rats treatmented with isulin, phlorizin and
tiron. (a) Lucigenin assay of the STZ-diabetic rats. Western blot
analysis of (b) Klotho expression in the kidneys of STZ-diabetic
rats. Upper picture shows protein levels or the corresponding β-
actinlevelsshownasloadingcontrolsinkidneys isolatedfromSTZ-
d i a b e t i cr a t s .T h ed i ﬀerent treatments are described in materials
and methods. Quantiﬁcation of protein level using Klotho/β-actin,
expressed as means with SE (n = 4 per group) in each column are
presented in the lower panel. ∗P<. 05, ∗∗P< . 001 compared to
the value of vehicle-treated normal rats.
were performed using an ECL kit (Amersham Biosciences,
UK). Immunoblot densities were quantiﬁed using a laser
densitometer.
2.3. Histological Analysis. The kidney was removed from
each rat, ﬁxed in PBS containing 10% formaldehyde, and
embedded in paraﬃn. Each sample was then cut into 5-
μm sections, the sections were mounted on glass slides and
depleted of paraﬃn with xylene. Then sections are subjected
to standard hematoxylin/eosin staining. The sections were
observed with a light microscope.
2.4. Measurement of Reactive Oxygen Species (ROS) Gen-
eration. Superoxide production was determined using the
lucigenin method [11]. Renal homogenates were obtained
from normal rats or STZ rats following centrifugation. The
resultant pellet was then resuspended in 900μLo fK r e b s
buﬀer, containing 130mMNaCl, 5mMKCl, 1mMMgCl2,
1.5mMCaCl2,1m MK 2HPO4, and 20mMHEPES, pH 7.4,
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Figure 3: Changes in expression of Klotho in tubular cells (MDCK
cells) after exposure to high concentrations of glucose. Cultured
MDCK cells exposed to glucose at ﬁnal concentrations of 10mM,
20mM, 30mM and 40mM were used to compare with the
control, which was incubated with 5.5mM glucose. Cells were also
exposed to 24.5mM mannitol to produce the same osmolarity
(317mOsmol/L) as that produced when using the highest concen-
tration of glucose (30mM). After 24 hours of incubation, cells were
prepared for Western blot analysis. Quantiﬁcation of protein levels
using Klotho over β-actin indicated as means with SE (n = 4p e r
group) in each column are presented in the lower panel. ∗P<
.05, ∗∗P<. 001 compared to control.
with 1mg/mL bovine serum albumin. To measure ROS pro-
duction, the suspension were transferred into a measuring
chamber and assessed in a Chemiluminescence Analyzer
(Tohoku Electronic Industrial Co., Ltd., Japan). Measure-
ment was induced by an injection of 100μL lucigenin (ﬁnal
concentration, 4 × 10
−4 mmol/L). Photon emission was
counted every 10 seconds for up to 10 minutes.
2.5. Cell Cultures. The MDCK epithelial cells (BCRC no.
60004) were obtained from the Culture Collection and
Research Center of the Food Industry Institute (Hsin-Chiu
City, Taiwan), maintained in Minimum Essential Medium
(Gibco-BRL,USA),andsupplementedwith10%fetalbovine
serum and antibiotics. After cells reached approximately
60% conﬂuence, they were incubated in serum-free medium
with varying ﬁnal concentrations of D-glucose (5.5, 10,
20, 30 or 40mM) for 24 hours. MDCK cells exposed to
5.5mM D-glucose was used as the comparison condition.
To rule out an eﬀect of osmolarity, we added 24.5mM
mannitol into control cultures. We also treated MDCK
cells with tiron (10mmol/L, 4,5-dihydroxyl-1,3-benzene
disulfonic acid; Sigma-Aldrich Inc., Saint Louis, MO, USA).
After 24 hours of incubation, the cells were washed with PBS
and harvested. Hydrogen peroxide (H2O2) was diluted and
added into the culture medium at ﬁnal concentrations of 50,
100, and 150μmol/L. After 1 hour of H2O2 exposure, the
culture medium was replaced with serum-free medium for
another 23-hour culture period.
2.6.IntracellularROSDetection. ForintracellularROSdetec-
tion, 5000 MDCK cells were seeded into 12-well cell culture4 Journal of Biomedicine and Biotechnology
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Figure 4: DHE stains were used to visualize the intracellular ROS
in MDCK cells.
plates. After 24hr of growth, cultures were placed in either
control or high glucose (HG) medium, treated as described
above for 24hr and then harvested. The MDCK cells were
ﬁxed with 4% paraformaldehyde for 30min. After ﬁxation,
cells were washed three times with PBS, and 5μmol/L
of dihydroethidium (DHE; Invitrogen) was added as a
ﬂuorescent indicator of ROS. Images were collected with
an Olympus IX70 ﬂuorescence microscope ﬁtted with an
Olympus America camera and MagnaFire 2.1 software.
2.7. Statistical Analysis. Statistical analysis was carried out
using ANOVA analysis and Newman-Keuls Post-hoc analy-
sis. Statistical signiﬁcance was achieved if the P<. 05. Results
were expressed as mean ± SE.
3. Results
3.1. Eﬀect of Insulin or Phloridzin on Rats with Diabetic
Nephropathy. After 9 weeks of diabetes induction, the serum
levels of glucose, BUN, and creatinine in STZ rats were
markedly higher than in age-matched normal rats (Table 1);
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Figure 5: Changes in Klotho expression levels in cultured MDCK
cells. (a) Western blot analysis of Klotho expression in normal
glucose (5mmol/L) medium in MDCK cells treated with H2O2.
Upper picture shows the protein level of Klotho or actin in MDCK
cells. ∗∗P<. 001comparedtoMDCKcellswithoutH2O2 treatment.
Western blot analysis was used to detect Klotho (b) expression in
MDCK cells cultured with normal glucose (5mmol/L; control) or
high glucose (40mmol/L glucose; HG) medium with or without
tiron (10mmol/L) treatment. Upper picture shows the protein level
of Klotho or actin in MDCK cells. Quantiﬁcation of protein levels
indicated as means with SE (n = 4 per group) in each column are
presented in the lower panel. ∗∗P<. 001 compared to control.
marked diﬀerence in BUN and creatinine levels between
the two groups were observed (P<. 05). HE (hematoxylin
and eosin stain) staining also showed structural defects
of glomerosclerosis and tubular thickness in STZ rats
(Figure 1(b), black arrows). After treatment with insulin or
phloridzin for 7 days, the serum glucose was signiﬁcantly
reduced in STZ rats (Table 1). BUN and creatinine levels in
insulin- or phloridzin-treated STZ rats were also decreased
(Table 1). These treatments ameliorated glomerosclerosis
and improved tubular thickness, as observed by HE staining
(Figures 1(c)–1(d),b l a c ka r r o w s ) .
3.2. Eﬀect of Antioxidant on Rats with Diabetic Nephropathy.
After a 7-day treatment with the antioxidant tiron, the
blood glucose level was not changed in STZ rats, similar toJournal of Biomedicine and Biotechnology 5
Table 1: Changes in blood glucose, BUN, and creatinine levels in streptozotocin-induced diabetic rats (STZ-DN) receiving repeated i.p.
injection with insulin (1IU/kg) or phloridzin (1mg/kg) three times per day for 7 days.
Normal rats-vehicle STZ-DN-vehicle STZ-DN-Insulin STZ-DN-Phloridzin
Before After Before After Before After Before After
Glucose (mg/dL) 118.3 ±12.1 121.8 ± 10.7 468.4 ±11a 473.1 ±6.2a 455.8 ±10.3 244.3 ±8.4b 488.3 ± 14.4 213.4 ±12.7b
BUN (mg/dL) 18.9 ±0.41 9 .1 ± 0.83 4 .3 ±0.4a 38.2 ±1.1a,b 34.6 ±1.82 3 .8 ±0.9b 32.6 ± 1.32 4 .5 ±1.4b
Creatinine (μg/dL) 612.3 ±11.2 605.4 ±9.8 717.8 ±11.6a 744.2 ±3.9a 787.2 ±14.7 674.2 ±8.6b 817.6 ± 26.5 634.9 ±11.7b
Values (mean ± SE) were obtained from each group of six rats. The vehicle used to dissolve the testing drugs was given at the same volume. aP<. 05—for
values obtained from STZ-DN group compared to the values obtained from vehicle-treated normal rats. bP<. 05—for values after treatment compared to
the values of before vehicle, insulin or phloridzin treatment, respectively.
that in STZ rats receiving vehicle (Table 2). The lucigenin
assay showed that superoxide levels in diabetic kidneys were
markedly higher than normal kidneys (control) and these
levels were signiﬁcantly reduced by tiron (Figure 2(a)). The
blood levels of BUN and creatinine in tiron-treated STZ rats
were also improved (Table 2). Additionally, expression levels
of Klotho were decreased in STZ rats, and these levels could
be restored in kidneys of diabetic rats treated with tiron
(Figure 2(b)). From HE staining, rehabilitation of structural
change was also observed in kidney receiving tiron treatment
(Figure 1(e),b l a c ka r r o w s ) .
3.3. Recovery of Renal Klotho due to Decreased Levels of
ROS. Changes in klotho expression in kidneys from STZ
rats were characterized using Western Blot analysis. Klotho
expression in kidney of STZ rats was markedly reduced
as compared to control group (Figure 2(b)). Insulin or
phloridzin treatment reversed Klotho expression in kidney
o fS T Zr a t s( Figure 2(b)). Similar results were also observed
in tiron-treated kidney (Figure 2(b)).
3.4. Decrease of Klotho Expression Levels by Glucose in
Tubular Cells. Eﬀect of hyperglycemia on Klotho expression
levels was further characterized in cultured MDCK cells
exposed to various concentrations of glucose in vitro. The
Klotho expression in MDCK cells was reduced by high
glucose in a concentration-dependent manner after 24-hr
incubation (Figure 3). But the Klotho expression levels were
not changed in mannitol-treated MDCK cells, indicating
that the mediation of hyperosmolarity does not reduced
klotho levels. Actually, decrease of Klotho expression by high
glucose in MDCK cells is similar to that observed in diabetic
kidneys (Figure 2(b)). From the detection of DHE staining,
we also demonstrated that high glucose caused an increase in
superoxide levels in MDCK cells and that tiron reduced ROS
in glucose-treated MDCK cells (Figure 4).
3.5. Decrease of Klotho Expression Level in MDCK Cells by
ROS from High Glucose. ROS are excessively produced in
the pathogenesis of acute and chronic renal diseases [12].
To understand the eﬀect of ROS on Klotho expression, we
treated MDCK cells with hydrogen peroxide (H2O2) directly
and then we examined the changes of Klotho expression
using Western Blot analysis. As shown in Figure 5(a),H 2O2
decreased Klotho expression in MDCK cells. High glucose-
induced ROS is believed to be one of the main factors
in the pathogenesis of diabetic nephropathy [7]. Thus,
we treated MDCK cells in high glucose (40mmol/L; HG)
medium with and without 10mmol of tiron, a superoxide
anion scavenger [8]. The DHE ﬂuorescence staining was
applied to conﬁrm the increase of ROS in HG-treated
MDCKcells(Figure 2(b)) and mamnitol was used to exclude
the role of hyperosmolarity. As shown in Figure 5(b), the
lowering of Klotho protein in MDCK cells by high glucose
concentrations was markedly reversed by tiron treatment.
4. Discussion
In the present study, we found that hyperglycemia caused
poor renal function and lower expression of Klotho protein
in diabetic kidney, and these defects could be reversed by
correction of blood glucose levels using insulin or phloridzin
treatment in diabetic rats. We used STZ to induce type-1
like diabetes in rats according to previous report [8]. After 9
weeks,diabeticratsdevelopeddiabeticnephropathyshowing
typical features of this disorder, such as higher creatinine
and BUN levels in blood [13]. Although, Proteinuria was not
measured in the present study.
Insulin and phloridzin have the ability to lower blood
glucose levels in diabetic animals through diﬀerent mecha-
nisms; insulin decreases blood glucose via receptor-coupled
signaling [14] and phloridzin acts as an inhibitor of renal
tubular reabsorption of glucose [10]. A 7-day correction
of hyperglycemia with insulin or phloridzin-improved renal
function in STZ-induced diabetic rats. These results support
the view that blood glucose control can reduce the incidence
of diabetic nephropathy [12].
It has been demonsted that Klotho-overexpressed mice
showed increased SOD2 expression in muscles and low levels
of phosphorylated Forkhead box O proteins (FOXOs), in
additiontothereducedoxidativestressasevidencedbylower
levels of urinary 8-OHdG, a marker of oxidative damages to
DNA [15]. Also, they survived normally lethal quantities of
injected paraquat, a herbicide that generates reactive oxygen
species(ROS),indicatingthatKlothooverexpressioninduces
resistance to oxidative stress. Klotho could activate FOXOs,
induce SOD2 expression, and confer resistance to oxidative
damages and apoptosis induced by paraquat or hydrogen
peroxide[16].Oxidativestressisinvolvedinthepathogenesis6 Journal of Biomedicine and Biotechnology
Table 2: Changes in serum glucose, BUN, and creatinine levels in normal rats or streptozotocin-induced diabetic rats (STZ-DN) receiving
repeated i.p. injection with vehicle or tiron (300 mg/kg) three times a day for 7 days.
Normal rats-vehicle STZ-DN-vehicle STZ-DN-tiron
Before After Before After Before After
Glucose (mg/dL) 116.3 ±5.2 122.9 ±5.3 478.2 ±13.8a 483.7 ±14.5a 481.8 ±13.7a 473.2 ±12.3a
BUN (mg/dL) 18.2 ±0.81 6 .3 ±0.82 9 .8 ±0.7a 31.9 ±1.2a 31.4 ±0.4a 22.3 ±0.5
Creatinine (μg/dL) 612.7 ±9.8 621.4 ±4.6 723.6 ±21.8a 753.7 ±11.4ab 744.6 ±12.3a 614.8 ±26.8b
Values (mean ± SE) were obtained from each group of six animals. The vehicle used to dissolve the testing drugs was given at the same volume. aP<. 05
compared to the values of control, bP<. 05 compared to the values of before vehicle or tiron treatment.
of various diseases, including ischemia and inﬂammation.
Renal Klotho expression was signiﬁcantly suppressed in
the kidney subjected to experimental injury by H2O2 [17].
Also, higher expression of Klotho prevented ischemic renal
damages and the development of acute renal failure [2, 18].
These observations suggest that Klotho seems related to the
induction of resistance to oxidative stress. This view was
consistent with our results both in kidney of STZ rats and
cultured renal tubular cells. In the present study, STZ rats
treated with tiron at doses suﬃcient to scavenge free radicals
continuously for 7 days showed a recovery of renal function
without the correction of blood glucose. The decrease of
Klotho expression in kidney of STZ rats was also reversed
by tiron treatment with a marked reversion of structural
defeats. The important role of oxidative stress in damage of
diabetic kidney can be considered. Moreover, the reduced
expression of Klotho in cultured renal tubular cells caused
by high glucose was also reversed by the antioxidant tiron.
Thus, antioxidants could provide eﬀective protection against
the oxidative stress through Klotho expression in diabetic
nephropathy.
Klotho plays a major role in the protection of kidney due
to antioxidation [2, 18] relating with PPAR-gamma [9]. It
has been established that high glucose caused an excessive
production of ROS [7]. Improvements in diabetes-induced
renal dysfunction and diabetic nephropathy by antioxidants
is evidence for an important role of ROS in kidney damage
[5]. Klotho expression was reduced under hyperglycemic
condition in kidney and renal tubular cells. It can be
considered that decrease of Klotho expression is related to
the process of diabetic nephropathy. This view has not been
mentioned before. Otherwise, Klotho has been introduced
as a cofactor of ﬁbroblast growth factor 23 (FGF23)-induced
phosphate excretion in kidney [17]. According to our results,
phosphate excretion was actually decreased in STZ rats with
a marked lower of Klotho expression (data not shown).
However, the role of FGF-23 in this change shall be studied
in the future.
5. Conclusion
In the present study, Klotho expression is decreased in
the kidney of STZ rats showed diabetic nephropathy. This
decreased Klotho expression can be reversed by antioxidant
without the correction of blood glucose. Thus, we suggest
that antioxidants and/or agents can increase Klotho expres-
sion may have the merit in the prevention of renal damage
from oxidative stress produced in diabetic disorders.
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